Sarepta to pause gene therapy Elevidys shipments in US – Reuters
- Sarepta to pause gene therapy Elevidys shipments in US Reuters
- Third death from a Sarepta gene therapy BioCentury
- Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label Sarepta Therapeutics
- Post-Hoc Live: What’s next with Sarepta and its showdown with the FDA? Endpoints News
- MHE Week in Review – International AIDS Society (IAS) 2025 Meeting Coverage Managed Healthcare Executive